ArtVentive EOS Peripheral Vascular Enoluminal Occlusion system receives CE Mark certification

Download PDF Copy

Jun 1 2013

ArtVentive Medical Group, Inc. (OTC Bulletin Board: AVTD) announced today that the Company has received its European CE Mark certification for the ArtVentive EOS™ Peripheral Vascular Enoluminal Occlusion system.

“This is a very significant achievement in the Company's history as it moves toward commercialization and its planned launch into the European markets”

"This is a very significant achievement in the Company's history as it moves toward commercialization and its planned launch into the European markets," stated Dr. Leon Rudakov, President and CTO. "The CE Mark also paves the way to facilitate approvals for the ArtVentive EOS™ device internationally in meeting with the Company's global mandate," stated Jim Graham, CEO and Chairman.

SOURCE ArtVentive Medical Group, Inc.

Posted in: Device / Technology News

Comments (0)

Download PDF Copy

Suggested Reading

Weight loss wipes out senescent fat cells but leaves immune scars, study finds

Experts warn tiny plastics in arteries may raise heart attack risk

Nigerian botanicals restore hormonal balance and fight menstrual pain in preclinical study

COVID-19 accelerates vascular aging in women

GIPR signaling opens brain’s gate for GLP-1 weight-loss therapy

Cannabis smoking changes your DNA, leaving epigenetic scars

Erythritol alters brain vessel function and may raise stroke risk

COVID-19 ages arteries prematurely with women most affected

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.